These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1117978

  • 1. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB, Scott CL, Modebe O, Bethune JE.
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [Abstract] [Full Text] [Related]

  • 2. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G, Masala A.
    Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
    [Abstract] [Full Text] [Related]

  • 3. Action of somatostatin, levodopa and pyridoxine on growth hormone (GH) secretion in newborn infants.
    Delitala G, Meloni T, Masala A, Alagna S, Devilla L, Costa R.
    Biomedicine; 1978 Feb; 29(1):13-5. PubMed ID: 667280
    [Abstract] [Full Text] [Related]

  • 4. Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.
    Delitala G, Masala A, Alagna S, Devilla L.
    J Clin Endocrinol Metab; 1976 Mar; 42(3):603-6. PubMed ID: 1254699
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M, Klimes I, Jurcovicova J, Kolesar P, Repcekova-Jezova D.
    Diabete Metab; 1977 Dec; 3(4):257-8. PubMed ID: 598566
    [Abstract] [Full Text] [Related]

  • 7. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K.
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [Abstract] [Full Text] [Related]

  • 8. Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects.
    Vizner B, Reiner Z, Sekso M.
    Exp Clin Endocrinol; 1983 Jan; 81(1):41-8. PubMed ID: 6343098
    [Abstract] [Full Text] [Related]

  • 9. Effect of pyridoxine on pituitary release of growth hormone and prolactin in childhood and adolescence.
    Reiter EO, Root AW.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):689-90. PubMed ID: 263321
    [Abstract] [Full Text] [Related]

  • 10. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P, Knip M, Lautala P, Leppäluoto J.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [Abstract] [Full Text] [Related]

  • 11. Reduced growth hormone response to L-dopa and pyridostigmine in obesity.
    Lee EJ, Kim KR, Lee KM, Lim SK, Lee HC, Lee JH, Lee DJ, Huh KB.
    Int J Obes Relat Metab Disord; 1994 Jul; 18(7):465-8. PubMed ID: 7920871
    [Abstract] [Full Text] [Related]

  • 12. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H, Yen SS.
    Am J Obstet Gynecol; 1976 Sep 15; 126(2):162-4. PubMed ID: 961756
    [Abstract] [Full Text] [Related]

  • 13. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
    Jorgensen EV, Schwartz ID, Hvizdala E, Barbosa J, Phuphanich S, Shulman DI, Root AW, Estrada J, Hu CS, Bercu BB.
    J Pediatr Endocrinol; 1993 Sep 15; 6(2):131-42. PubMed ID: 8102303
    [Abstract] [Full Text] [Related]

  • 14. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD, Lantigua R, Lee LA.
    J Clin Endocrinol Metab; 1979 Sep 15; 49(3):326-30. PubMed ID: 468965
    [No Abstract] [Full Text] [Related]

  • 15. Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
    Bellastella A, Parlato F, Sinisi AA.
    J Clin Endocrinol Metab; 1990 Apr 15; 70(4):856-8. PubMed ID: 2318945
    [Abstract] [Full Text] [Related]

  • 16. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J, Moraru E, Altszuler N.
    Pharmacology; 1978 Apr 15; 17(3):138-48. PubMed ID: 704657
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
    Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML.
    J Clin Endocrinol Metab; 2002 May 15; 87(5):2067-79. PubMed ID: 11994342
    [Abstract] [Full Text] [Related]

  • 18. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov 15; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 19. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome.
    Hagen TC, Sill AJ, Garthwaite TL, Halverson G, Borkowf HI.
    Obstet Gynecol; 1980 Aug 15; 56(2):204-7. PubMed ID: 7190256
    [Abstract] [Full Text] [Related]

  • 20. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 15; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.